Chemomab Therapeutics Ltd. (CMMB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chemomab Therapeutics Ltd...

    NASDAQ: CMMB · Real-Time Price · USD
    2.72
    0.02 (0.74%)
    At close: Oct 03, 2025, 3:59 PM
    2.71
    -0.37%
    After-hours: Oct 03, 2025, 04:37 PM EDT

    Chemomab Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -9.32 -0.99 -5.27 -22.94
    PEG Ratio
    		 0.15 0.06 -0.05 0.28
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 9.60 1.41 4.02 4.66
    P/FCF Ratio
    		 -8.45 -1.02 -7.13 -22.7
    P/OCF Ratio
    		 -8.41 -1.02 -7.15 -23.14
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.02 0.01 0.01
    Quick Ratio
    		 4.98 4.32 6.18 24.16
    Current Ratio
    		 4.98 4.32 6.18 23.66
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -80.83 -111.34
    Return on Equity
    		 -1.03 -1.43 -0.76 -0.2
    Return on Assets
    		 -0.82 -1.09 -0.64 -0.19
    Return on Invested Capital
    		 -1.05 -1.46 -0.77 -0.2
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist